Impaired binding of drugs and endogenous ligands in renal diseases.
D001032:Apazone / Q000378:metabolism; D001663:Bilirubin / Q000378:metabolism; D001665:Binding Sites; D002352:Carrier Proteins; D003975:Diazepam / Q000378:metabolism; D004074:Digitoxin / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D006207:Half-Life; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007211:Indoles / Q000378:metabolism; D007674:Kidney Diseases / Q000378:metabolism*; D007676:Kidney Failure, Chronic / Q000628:therapy; D007700:Kinetics; D008024:Ligands; D008099:Liver / Q000378:metabolism; D008722:Methods; D011485:Protein Binding; D011487:Protein Conformation; D006435:Renal Dialysis; D012709:Serum Albumin / Q000378:metabolism; D014118:Toxins, Biological / Q000378:metabolism; D014511:Uremia / Q000378:metabolism; D014859:Warfarin / Q000378:metabolism
D002352:Carrier Proteins; D005230:Fatty Acids, Nonesterified; D007211:Indoles; D008024:Ligands; D012709:Serum Albumin; D014118:Toxins, Biological; D014859:Warfarin; D004074:Digitoxin; D001032:Apazone; D003975:Diazepam; D001663:Bilirubin